BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15818544)

  • 1. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
    Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of continuous veno-venous hemofiltration on acid-base balance.
    Rocktäschel J; Morimatsu H; Uchino S; Ronco C; Bellomo R
    Int J Artif Organs; 2003 Jan; 26(1):19-25. PubMed ID: 12602465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration.
    Egi M; Naka T; Bellomo R; Langenberg CC; Li W; Fealy N; Baldwin I
    Int J Artif Organs; 2008 Mar; 31(3):228-36. PubMed ID: 18373316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-base balance during continuous veno-venous hemofiltration: the impact of severe hepatic failure.
    Naka T; Bellomo R; Morimatsu H; Rocktaschel J; Wan L; Gow P; Angus P
    Int J Artif Organs; 2006 Jul; 29(7):668-74. PubMed ID: 16874671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration.
    Jacobs R; Honore PM; Diltoer M; Spapen HD
    BMC Nephrol; 2016 Aug; 17(1):119. PubMed ID: 27562561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting.
    Naka T; Egi M; Bellomo R; Cole L; French C; Botha J; Wan L; Fealy N; Baldwin I
    Anaesth Intensive Care; 2005 Oct; 33(5):601-8. PubMed ID: 16235478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionic homeostasis, acid-base balance and the risk of citrate accumulation in patients after cardiovascular surgery treated with continuous veno-venous haemofiltration with post-dilution regional citrate anticoagulation - An observational case-control study.
    Kośka A; Kowalik MM; Lango-Maziarz A; Karolak W; Jagielak D; Lango R
    Acta Biochim Pol; 2021 Oct; 68(4):695-704. PubMed ID: 34714613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
    Liu DL; Huang LF; Ma WL; Ding Q; Han Y; Zheng Y; Li WX
    Chin Med J (Engl); 2016 Jul; 129(14):1682-7. PubMed ID: 27411455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acid-base effects of continuous hemofiltration with lactate or bicarbonate buffered replacement fluids.
    Tan HK; Uchino S; Bellomo R
    Int J Artif Organs; 2003 Jun; 26(6):477-83. PubMed ID: 12866653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC; Wille KM; Speer R; Tolwani AJ
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration.
    Egi M; Naka T; Bellomo R; Cole L; French C; Trethewy C; Wan L; Langenberg CC; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Dec; 28(12):1211-8. PubMed ID: 16404696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study.
    Aman J; Nurmohamed SA; Vervloet MG; Groeneveld AB
    J Crit Care; 2010 Mar; 25(1):120-7. PubMed ID: 19427760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Hemodial Int; 2013 Apr; 17(2):313-20. PubMed ID: 22882732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
    Fealy N; Baldwin I; Johnstone M; Egi M; Bellomo R
    Int J Artif Organs; 2007 Apr; 30(4):301-7. PubMed ID: 17520566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong ion difference and CVVH: Different response during nadroparin versus citrate anticoagulation.
    Buter H; Koopmans M; van der Voort PHJ
    J Crit Care; 2018 Oct; 47():88-92. PubMed ID: 29936328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.